San Diego?s Mirum Pharmaceuticals said Wednesday it has raised $120 million in venture capital funding. The newly formed biomedical company will use the money to complete development of an unsuccessful pediatric liver disease drug it has acquired and plans to revive.
The orally taken drug, maralixibat,…
